Читать книгу Practical Cardiovascular Medicine - Elias B. Hanna - Страница 237

1 93. Dauerman HL. Reasonable incomplete revascularization. Circulation 2011; 123: 2337–40.

2 94. Farooq V, Serruys PW, Garcia-Garcia HM, et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX trial. J Am Coll Cardiol 2013; 61: 282–94. Incomplete revascularization, whether with CABG or PCI, was associated with impaired long-term outcomes in SYNTAX trial (≠ references 96-98).

3 95. Hannan EL, Wu C, Walford G, et al. Incomplete revascularization in the era of drug-eluting stents: impact on adverse outcomes. JACC Cardiovasc Interv 2009; 2: 17–25.

4 96. van den Brand MJ, Rensing BJ, Morel MA, et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol. 2002; 39: 559–564.

5 97. Rastan AJ, Walther T, Falk V et al. Does reasonable incomplete surgical revascularization affect early or long-term survival in patients with multivessel coronary artery disease receiving left internal mammary artery bypass to left anterior descending artery? Circulation 2009; 120: S70–7.

6 98. Vander Salm TJ, Kip KE, Jones RH, et al. What constitutes optimal surgical revascularization? Answers from the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 2002; 39: 565–72.